Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
Representative of Ebolavirus gender, Filoviridae family, Ebola virus is an etiological agent of particularly dangerous viral fever, the lethality of which comes up to 88 %. According to the leading specialists and experts in the sphere, vaccination is the most effective and cost-efficient method for...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
2015-09-01
|
Series: | Проблемы особо опасных инфекций |
Subjects: | |
Online Access: | https://journal.microbe.ru/jour/article/view/255 |
id |
doaj-8b50be27e9424811a149ec6cf12c2c32 |
---|---|
record_format |
Article |
spelling |
doaj-8b50be27e9424811a149ec6cf12c2c322021-07-22T07:51:38ZrusFederal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”Проблемы особо опасных инфекций0370-10692658-719X2015-09-010310410910.21055/0370-1069-2015-3-104-109255Current State of the Development of Next-Generation Vaccines against Ebola Virus DiseaseT. E. Sizikova0V. N. Lebedev1S. V. Borisevich2D. A. Kutaev3I. V. Borisevich4The 48th Central Research Institute of the RF Ministry of DefenseThe 48th Central Research Institute of the RF Ministry of DefenseThe 48th Central Research Institute of the RF Ministry of DefenseThe 48th Central Research Institute of the RF Ministry of DefenseScientific Center on Expertise of Medical Application ProductsRepresentative of Ebolavirus gender, Filoviridae family, Ebola virus is an etiological agent of particularly dangerous viral fever, the lethality of which comes up to 88 %. According to the leading specialists and experts in the sphere, vaccination is the most effective and cost-efficient method for the protection from epidemic spread. Objective of the review is to analyze current state of the development of next generation vaccines against Ebola fever. It is established that focus areas of the activities are the construction of vaccines on the basis of alpha-virus replicons, virus-like particles, and the development of DNA-vaccines and vector recombinant vaccines. The paper discusses the most significant achievements in the sphere of obtainment of potent therapies for prophylaxis as regards Ebola fever. To date manufactured, using various approaches, have been the next-generation vaccine preparations, for a number of which high protective capacity is demonstrated in the course of experiments on the nonhuman primates. The most advanced and prospective prototype is the vector recombinant vesicular stomatitis virus-based vaccine.https://journal.microbe.ru/jour/article/view/255вирус эболафиловирусыспецифическая профилактикавекторные рекомбинантные вакциныднк-вакцинывирусподобные частицырнк-репликоныаденовирусвирус везикулярного стоматитаebola virushemorrhagic feverfilovirusesspecific prophylaxisvector recombinant vaccinesdna-vaccinesvirus-like particlesrna-repliconsadenovirusvesicular stomatitis virus |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
T. E. Sizikova V. N. Lebedev S. V. Borisevich D. A. Kutaev I. V. Borisevich |
spellingShingle |
T. E. Sizikova V. N. Lebedev S. V. Borisevich D. A. Kutaev I. V. Borisevich Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease Проблемы особо опасных инфекций вирус эбола филовирусы специфическая профилактика векторные рекомбинантные вакцины днк-вакцины вирусподобные частицы рнк-репликоны аденовирус вирус везикулярного стоматита ebola virus hemorrhagic fever filoviruses specific prophylaxis vector recombinant vaccines dna-vaccines virus-like particles rna-replicons adenovirus vesicular stomatitis virus |
author_facet |
T. E. Sizikova V. N. Lebedev S. V. Borisevich D. A. Kutaev I. V. Borisevich |
author_sort |
T. E. Sizikova |
title |
Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease |
title_short |
Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease |
title_full |
Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease |
title_fullStr |
Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease |
title_full_unstemmed |
Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease |
title_sort |
current state of the development of next-generation vaccines against ebola virus disease |
publisher |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” |
series |
Проблемы особо опасных инфекций |
issn |
0370-1069 2658-719X |
publishDate |
2015-09-01 |
description |
Representative of Ebolavirus gender, Filoviridae family, Ebola virus is an etiological agent of particularly dangerous viral fever, the lethality of which comes up to 88 %. According to the leading specialists and experts in the sphere, vaccination is the most effective and cost-efficient method for the protection from epidemic spread. Objective of the review is to analyze current state of the development of next generation vaccines against Ebola fever. It is established that focus areas of the activities are the construction of vaccines on the basis of alpha-virus replicons, virus-like particles, and the development of DNA-vaccines and vector recombinant vaccines. The paper discusses the most significant achievements in the sphere of obtainment of potent therapies for prophylaxis as regards Ebola fever. To date manufactured, using various approaches, have been the next-generation vaccine preparations, for a number of which high protective capacity is demonstrated in the course of experiments on the nonhuman primates. The most advanced and prospective prototype is the vector recombinant vesicular stomatitis virus-based vaccine. |
topic |
вирус эбола филовирусы специфическая профилактика векторные рекомбинантные вакцины днк-вакцины вирусподобные частицы рнк-репликоны аденовирус вирус везикулярного стоматита ebola virus hemorrhagic fever filoviruses specific prophylaxis vector recombinant vaccines dna-vaccines virus-like particles rna-replicons adenovirus vesicular stomatitis virus |
url |
https://journal.microbe.ru/jour/article/view/255 |
work_keys_str_mv |
AT tesizikova currentstateofthedevelopmentofnextgenerationvaccinesagainstebolavirusdisease AT vnlebedev currentstateofthedevelopmentofnextgenerationvaccinesagainstebolavirusdisease AT svborisevich currentstateofthedevelopmentofnextgenerationvaccinesagainstebolavirusdisease AT dakutaev currentstateofthedevelopmentofnextgenerationvaccinesagainstebolavirusdisease AT ivborisevich currentstateofthedevelopmentofnextgenerationvaccinesagainstebolavirusdisease |
_version_ |
1721291762905907200 |